KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
Recruiting
Observational Study
Glomerular Disease
Minimal Change Disease
IgA Nephropathy
Membranous Nephropathy
Focal Segmental Glomerulosclerosis
Lupus Nephritis
Crescentic Glomerulonephritis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- Seoul National University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Glomerulonephritis (GN) generates an enormous individual and social economic burden. However, the therapeutic options are largely based on clinical and pathological parameters and the individual response to therapy or prognosis is uncertain.
Recently, along with advances in molecular analysis and computational bioinformatics, genomic data from human renal biopsies could provide a strong foundatio…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
1. Inclusion criteria
* Patient suspected of glomerular disease who received kidney biopsy in participating university medical centers
* Children (age\<18 years) also included
2. Exclusion criteria - Patients who previously received a kidney transplant
Contacts